Back to search

University of Glasgow

Recombinant Human Erythropoietin in the Treatment of Renal Anaemia

Abstract

dc:description.abstract

This thesis is concerned with a study of the clinical and biological effects of recombinant human erythropoietin (EPO) which recently became available as a novel treatment for the anaemia of end-stage renal disease. The dissertation begins with an introductory chapter which contains a historical note and survey of the relevant published literature. In this section is included a review of the pathogenesis of renal anaemia, the traditional treatment options for this condition, the development of recombinant human EPO, the biochemistry and physiology of erythropoietin, the metabolic fate of EPO, and the early clinical trials with EPO. This is followed by seven chapters of original work undertaken in Cardiff between April 1988 and July 1990.

Degree

thesis:*
Level dc:type.qualificationlevel
MD
Grantor dc:publisher.institution
University of Glasgow
Year dc:date.issued
1991

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • MacDougall, Iain Cumming

Rights

Language dc:language
en

Chain of custody

source
Harvested from
University of Glasgow
Base URL
theses.gla.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

MacDougall, Iain Cumming. Recombinant Human Erythropoietin in the Treatment of Renal Anaemia. MD thesis, University of Glasgow, 1991.